This difference was significant for T cell and total FXM results, as well as for the virtual crossmatch with C1q-binding antibodies, but only showed a trend for the B-cell FXM (Figure 3 ).
← all excerpts
Risk Stratification Before Living Donor Kidney Transplantation in Patients With Preformed Donor-specific Antibodies by Different Crossmatch Methods.
1
—
—